This brand name is authorized in Austria, Australia, Cyprus, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Italy, Lithuania, New Zealand, Poland, Turkey
The drug RAPILYSIN contains one active pharmaceutical ingredient (API):
1
Reteplase
UNII DQA630RIE9 - RETEPLASE
|
Reteplase is a recombinant plasminogen activator that catalyzes the cleavage of endogenous plasminogen to generate plasmin. This plasminogenolysis occurs preferentially in the presence of fibrin. Plasmin in turn degrades fibrin, which is the main component of the matrix of thrombi, thereby exerting its thrombolytic action. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
RAPILYSIN Powder and solvent for solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
B01AD07 | Reteplase | B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AD Enzymes |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 8253J |
Country: EE | Ravimiamet | Identifier(s): 1112241 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 159772 |
Country: FR | Base de données publique des médicaments | Identifier(s): 63335058 |
Country: HK | Department of Health Drug Office | Identifier(s): 43305 |
Country: IT | Agenzia del Farmaco | Identifier(s): 033131018 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1030616 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 7667 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100125566 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699638274796 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.